The NOD-like receptor protein 3 (NLRP3) inflammasome is a validated target for anti-inflammatory drug development. Upon activation by internal and external stimuli, NLRP3 mediates the release of ...
Rogers Sugar Inc.’s (the “Company”, “Rogers”, “RSI” or “our,” “we”, “us”) (TSX: RSI) today reported strong first quarter fiscal 2026 results, with consolidated adjusted EBITDA increasing by 18% to $46 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results